Burns - Pipeline Review, H2 2017

Publisher Name :
Date: 16-Aug-2017
No. of pages: 94
Inquire Before Buying

Burns - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burns - Pipeline Review, H2 2017, provides an overview of the Burns (Dermatology) pipeline landscape.

A burn is damage to body's tissues caused by heat, chemicals, electricity, sunlight or radiation. Symptoms include pain, increasing with each degree of burn, red and swollen skin, blisters and charred and blackened skin. Treatment includes antibiotics and pain relievers.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Burns - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Burns (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Burns (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 3, 4, 1, 14, 5 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Burns (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Burns (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Burns (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Burns (Dermatology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Burns (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Burns (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Burns (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Burns (Dermatology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Burns - Pipeline Review, H2 2017

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Burns - Overview 6
Burns - Therapeutics Development 7
Pipeline Overview 7
Pipeline by Companies 8
Pipeline by Universities/Institutes 11
Products under Development by Companies 12
Products under Development by Universities/Institutes 14
Burns - Therapeutics Assessment 15
Assessment by Target 15
Assessment by Mechanism of Action 17
Assessment by Route of Administration 19
Assessment by Molecule Type 21
Burns - Companies Involved in Therapeutics Development 23
AlgiPharma AS 23
Alliance Pharma Plc 23
Amarantus Bioscience Holdings Inc 24
American Gene Technologies International Inc 24
Anterogen Co Ltd 25
CytoTools AG 25
Destiny Pharma Ltd 26
Lakewood-Amedex Inc 26
Madam Therapeutics BV 27
MediWound Ltd 27
Phagelux Inc 28
Phosphagenics Ltd 28
Se-cure Pharmaceuticals Ltd 29
Stratatech Corp 29
USV Pvt Ltd 30
Burns - Drug Profiles 31
(cerium nitrate hexahydrate + silver sulfadiazine) - Drug Profile 31
A-3APO - Drug Profile 32
AG-110 - Drug Profile 34
albumin (recombinant) - Drug Profile 35
AyuV-25 - Drug Profile 36
Biologics for Multi Drug Resistant Bacterial Infections, Dermatology and Cystic Fibrosis - Drug Profile 37
bromelains - Drug Profile 38
Cell Therapy for Congenital Giant Hairy Nevus and Severe Burns - Drug Profile 42
Cell Therapy for Dermatology and Immunology - Drug Profile 44
ENERGIF-711 - Drug Profile 46
epidermal growth factor biosimilar - Drug Profile 47
Gene Therapy for Burns - Drug Profile 48
IMSP-001 - Drug Profile 49
ISN-001 - Drug Profile 50
lidocaine hydrochloride - Drug Profile 52
Monoclonal Antibody Conjugate to Inhibit TNF-Alpha for Burns, Inflammation and Wounds - Drug Profile 53
Neu-2000 - Drug Profile 54
NJ-01SS - Drug Profile 56
Nu-2 - Drug Profile 57
Oligomer G for Burn Wounds - Drug Profile 58
P-12 - Drug Profile 59
P-148 - Drug Profile 60
PEP-04 - Drug Profile 61
Protein to Activate FGFR for Dermatology, CNS, Cardiovascular and Musculoskeletal Disorders - Drug Profile 62
Recombinant Protein to Agonize EPCR for Wounds and Burns - Drug Profile 63
SC-106 - Drug Profile 64
SFR-9X0125 - Drug Profile 65
silver sulfadiazine - Drug Profile 66
Small Molecules for Burns - Drug Profile 67
sodium hypochlorite - Drug Profile 68
SST-024 - Drug Profile 69
Vanadis-02 - Drug Profile 70
XF-70 - Drug Profile 71
Burns - Dormant Projects 72
Burns - Discontinued Products 74
Burns - Product Development Milestones 75
Featured News & Press Releases 75
Appendix 90
Methodology 90
Coverage 90
Secondary Research 90
Primary Research 90
Expert Panel Validation 90
Contact Us 90
Disclaimer 91

List of Tables
Number of Products under Development for Burns, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Companies, H2 2017 (Contd..1), H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Burns - Pipeline by AlgiPharma AS, H2 2017
Burns - Pipeline by Alliance Pharma Plc, H2 2017
Burns - Pipeline by Amarantus Bioscience Holdings Inc, H2 2017
Burns - Pipeline by American Gene Technologies International Inc, H2 2017
Burns - Pipeline by Anterogen Co Ltd, H2 2017
Burns - Pipeline by CytoTools AG, H2 2017
Burns - Pipeline by Destiny Pharma Ltd, H2 2017
Burns - Pipeline by Lakewood-Amedex Inc, H2 2017
Burns - Pipeline by Madam Therapeutics BV, H2 2017
Burns - Pipeline by MediWound Ltd, H2 2017
Burns - Pipeline by Phagelux Inc, H2 2017
Burns - Pipeline by Phosphagenics Ltd, H2 2017
Burns - Pipeline by Se-cure Pharmaceuticals Ltd, H2 2017
Burns - Pipeline by Stratatech Corp, H2 2017
Burns - Pipeline by USV Pvt Ltd, H2 2017
Burns - Dormant Projects, H2 2017
Burns - Dormant Projects, H2 2017 (Contd..1), H2 2017
Burns - Discontinued Products, H2 2017

List of Figures
Number of Products under Development for Burns, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Top 10 Mechanism of Actions, H2 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Top 10 Molecule Types, H2 2017
Number of Products by Stage and Top 10 Molecule Types, H2 2017
  • China Hyaluronic Acid Based Dermal Fillers Market Research Report 2017
    Published: 08-Dec-2017        Price: US 3400 Onwards        Pages: 107
    The global Hyaluronic Acid Based Dermal Fillers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Hyaluronic Acid Based Dermal Fillers development status and future trend in China, focuses on top pl......
  • Global Hyaluronic Acid Dermal Filler Market Research Report 2017
    Published: 07-Dec-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global Hyaluronic Acid Dermal Filler market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hyaluronic Acid Dermal Filler in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Dermal Fillers Market Professional Survey Report 2017
    Published: 06-Dec-2017        Price: US 3500 Onwards        Pages: 106
    This report studies Dermal Fillers in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Allergan - Galderma - LG LIFE & SCIENCE - Bloomage Bio Technology......
  • China Acne Drugs Market Research Report 2017
    Published: 06-Dec-2017        Price: US 3400 Onwards        Pages: 112
    The global Acne Drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies the Acne Drugs development status and future trend in China, focuses on top players in China, also splits Acne Drugs by type and b......
  • China Botox Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022
    Published: 04-Dec-2017        Price: US 4480 Onwards        Pages: 122
    Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species in the reproduction process. Botox is a polypeptide which molecular weight is 150kD and is also one of the most poisonous natural proteins. It is so easy to be produced, purified and refined due to its stable property that Botox is used widely in Experimental Research and Clinical Application at the early stage. Scope of the Report: This report focuses on the Botox in China mar......
  • Global Facial Injectables Market Professional Survey Report 2017
    Published: 01-Dec-2017        Price: US 3500 Onwards        Pages: 112
    This report studies Facial Injectables in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Allergan - Prollenium Medical Technologies Inc - Galderma - Merz ......
  • 2017-2022 China Onychomycosis (Tinea Unguium) Drug Market Report (Status and Outlook)
    Published: 01-Dec-2017        Price: US 3360 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the Onychomycosis (Tinea Unguium) Drug market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Johnson & Johnson GSK Novartis Pfizer Valeant Pharma Kaken Pharmace......
  • 2017-2022 Global Top Countries Onychomycosis (Tinea Unguium) Drug Market Report
    Published: 01-Dec-2017        Price: US 4960 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." In 2016, the global Onychomycosis (Tinea Unguium) Drug market size was xx million USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Onychomycosis (Tinea Unguium) Drug in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia,......
  • 2017 Top 5 Onychomycosis (Tinea Unguium) Drug Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 01-Dec-2017        Price: US 4960 Onwards        Pages: 118
    "This report will be delivered in 2-3 business days after the order is placed." The Global Onychomycosis (Tinea Unguium) Drug market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Onychomycosis (Tinea Unguium) Drug market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Afric......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs